Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxol/Carboplatin as First Line Therapy in Epithelial Ovarian Cancer
NCT00170664Phase 2Completed
- Sponsor
- NOGGO
- Start
- Jan 1999
- Primary completion
- Mar 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and carboplatin in ovarian cancer, sponsored by NOGGO. Started Jan 1999; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00170664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170664.